Tag: tenofovir

CATALYST HIV Research Study Launched In Zimbabwe

Michael Gwarisa

THE Maximizing Options to Advance Informed Choice for HIV Prevention (MOSAIC) consortium, has launched CATALYST, a research study that evaluates delivery of HIV prevention methods in women and girls at greater risk oF new HIV infections. By Michael Gwarisa The three-year, multi-country implementation study builds on decades of research related to pre-exposure prophylaxis (PrEP) for HIV prevention and is aimed at assessing the delivery of multiple PrEP methods to women in real-world settings in five African countries, including Zimbabwe. The study will deliver choice among three PrEP methods — daily…

Read More

#BREAKING: Zim To Switch To New ARV Drug With Less Side Effects

NewsRoom

ZIMBABWE is ready to transition to Teno-Lamuvudine Dolutegrevir (TLD), an Anti-retro Viral (ARV) drug with less side effects, moving away from the Teno-Lamivudine-Efavirenz (TLE) a three in one drug that is taken once a day, a top health official has said By Michael Gwarisa The development comes barely a year after government through the Ministry of Health and Child Care (MoHCC) deferred rolling out of the Dolutegrevir drug following indications that it posed a great risk to women of child bearing age and adolescent girls which might lead to women…

Read More